More European HTA collaboration likely, but no EuroNICE
This article was originally published in SRA
It seems likely that there will be more collaboration on healthcare technology assessments across the EU in a bid to reduce the 27 plus "hurdles to market access" following marketing approval1. However, a "EuroNICE" that would rule on cost-effectiveness for all member states is unlikely.
You may also be interested in...
Performance-based managed entry agreements need to be made more effective, but this can only happen if countries relax their stance on confidentiality and share information on MEAs amongst themselves, says a working paper from the OECD.
The Netherlands will secure lower medicine prices by referencing Norway instead of Germany to set maximum prices.
Luxembourg’s new regulator will work to attract investment and improve public health as well as tackle the growing problem of drug shortages.